Ard Podcast
TULIP 1 - highlights from the ACR meeting
- Author: Vários
- Narrator: Vários
- Publisher: Podcast
- Duration: 0:04:51
- More information
Informações:
Synopsis
TULIP 1: A Phase 3 Randomized Controlled Trial of Anifrolumab in Patients with Moderate to Severe Systemic Lupus Erythematosus In this first phase 3 trial, the primary endpoint, SRI(4), was not achieved, but numeric improvements achieving thresholds associated with clinical benefit were observed for BICLA, oral corticosteroid tapering and other organ-specific endpoints.